GLIS3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.608800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.292800E-01
Normal-vs-Stage2
4.628400E-01
Normal-vs-Stage3
3.351800E-01
Normal-vs-Stage4
4.454000E-01
Stage1-vs-Stage2
4.285800E-01
Stage1-vs-Stage3
1.909360E-01
Stage1-vs-Stage4
8.754600E-01
Stage2-vs-Stage3
2.768200E-01
Stage2-vs-Stage4
6.589600E-01
Stage3-vs-Stage4
1.706150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.585000E-01
Normal-vs-AfricanAmerican
4.551400E-01
Normal-vs-Asian
1.369960E-01
Caucasian-vs-AfricanAmerican
5.289600E-01
Caucasian-vs-Asian
6.193600E-01
AfricanAmerican-vs-Asian
5.218800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.643200E-01
Normal-vs-Female
4.570800E-01
Male-vs-Female
8.754600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.295800E-01
Normal-vs-Age(41-60Yrs)
5.307400E-01
Normal-vs-Age(61-80Yrs)
4.360600E-01
Normal-vs-Age(81-100Yrs)
3.855800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.683000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.289000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.210200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.797700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.138440E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.698600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.335600E-01
Normal-vs-Daily Drinker
3.521200E-01
Normal-vs-Weekly Drinker
4.904800E-01
Normal-vs-Occasional Drinker
3.794600E-01
Normal-vs-Social Drinker
5.122800E-01
Non Drinker-vs-Daily Drinker
1.873600E-01
Non Drinker-vs-Weekly Drinker
5.382600E-01
Non Drinker-vs-Occasional Drinker
4.596600E-01
Non Drinker-vs-Social Drinker
3.991800E-01
Daily Drinker-vs-Weekly Drinker
4.411700E-02
Daily Drinker-vs-Occasional Drinker
6.710600E-01
Daily Drinker-vs-Social Drinker
2.538300E-02
Weekly Drinker-vs-Occasional Drinker
2.094400E-01
Weekly Drinker-vs-Social Drinker
8.303400E-01
Occasional Drinker-vs-Social Drinker
1.449960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.380400E-01
Normal-vs-Grade 2
2.969600E-01
Normal-vs-Grade 3
2.095800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.888600E-01
Grade 1-vs-Grade 3
4.608000E-01
Grade 1-vs-Grade 4
5.380400E-01
Grade 2-vs-Grade 3
4.015400E-01
Grade 2-vs-Grade 4
2.969600E-01
Grade 3-vs-Grade 4
2.095800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.279000E-01
Normal-vs-NonDiabetic
4.493400E-01
Diabetic-vs-NonDiabetic
6.409200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.731400E-01
Normal-vs-NoPancreatitis
4.523000E-01
Pancreatitis-vs-NoPancreatitis
2.610600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.292800E-01
Normal-vs-N1
4.844800E-01
N0-vs-N1
2.494600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.007400E-01
Normal-vs-TP53-NonMutant
4.988200E-01
TP53-Mutant-vs-TP53-NonMutant
1.322800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
